NIH-funded research NIH-funded research

Creating a new inhalable COVID-19 vaccine that doesn't need refrigeration

Official title: Design and development of a novel, thermostable, and inhalable dry powder COVID-19 vaccine

Funded at St. John's University · NIH-10794969 · Data updated 2026-11-12

This study is testing a new inhalable COVID-19 vaccine that doesn't need to be kept cold, making it easier to give to people, especially in hard-to-reach places or during emergencies.

More COVID-19 research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSt. John's University
NIH-funded
Lab location1 site (Queens, United States)
Project startApril 20, 2022
Project endMarch 31, 2026
Funding year2024
Award (this year)$164,000
NIH project number5SC2GM144157-03
Project IDNIH-10794969 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who are at higher risk for severe COVID-19, such as those with co-morbidities like diabetes or hypertension.

Less likely to help

Patients who are not at risk for COVID-19 or those who have already been vaccinated with existing vaccines may not benefit from this research.

What this research studies

This research focuses on developing a novel COVID-19 vaccine that can be inhaled and does not require refrigeration, making it easier to distribute and administer. The vaccine utilizes liposomes to deliver the spike protein of the virus, which is crucial for generating an immune response. By mimicking the virus's natural presentation, the vaccine aims to enhance the body's ability to fight off COVID-19. This approach is particularly important for reaching populations in remote areas or during emergencies when traditional vaccines may not be viable.

Why it matters

Potential benefit: If successful, this research could provide a more accessible and effective way to vaccinate against COVID-19, especially in underserved communities.

How similar studies have gone: While there have been successful developments in traditional COVID-19 vaccines, this inhalable and thermostable approach is relatively novel and has not been widely tested.

Where this research is happening

  • St. John's University
    Queens, United States
    Active

Researchers

  • Principal investigator: Kunda, Nitesh K — St. John's University
  • Study coordinator: Kunda, Nitesh K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.